AviadoBio acquires rights to gene therapies’ new delivery technology – ALS News Today
AviadoBio entered into a worldwide exclusive agreement with NeuroGain to develop and commercialize a gene therapy spinal delivery for ALS. Read source
Click to rate this post!
[Total: 0 Average: 0]